(Total Views: 650)
Posted On: 03/18/2025 5:49:13 PM
Post# of 154912
So this, is what Dr. J means when said: " The impressive survival observations at 12, 24, and 36 months in patients who previously failed treatment in the metastatic or locally advanced setting indicate leronlimab could play a significant role as a paradigm-shifting therapeutic in oncology."
From medical sites:
Locally advanced breast cancer (LABC) signifies breast cancer that has grown significantly and spread to nearby tissues (skin, chest wall, or lymph nodes) but not to distant organs, often referred to as Stage III breast cancer.
Leronlimab addressed in our survivors:
Tumor - Tissue(s) - Metastasis.
We know Metastasis kills 90% of patients.
Dr. J informed that all 3 stages are addressed by Leronlimab.
WOW!!
From medical sites:
Locally advanced breast cancer (LABC) signifies breast cancer that has grown significantly and spread to nearby tissues (skin, chest wall, or lymph nodes) but not to distant organs, often referred to as Stage III breast cancer.
Leronlimab addressed in our survivors:
Tumor - Tissue(s) - Metastasis.
We know Metastasis kills 90% of patients.
Dr. J informed that all 3 stages are addressed by Leronlimab.
WOW!!
(10)
(0)
